HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of 5,7-dihydroxytryptamine on audiogenic seizures in genetically epilepsy-prone rats.

Abstract
To further assess the role of 5-HT in the modulation of audiogenic seizures (AGS) in the Genetically Epilepsy-Prone Rat (GEPR), changes in AGS severity after widespread chronic depletion of brain 5-HT by intracerebroventricular administration of 5,7-dihydroxytryptamine (5,7-DHT) were examined in moderate seizure GEPRs (GEPR-3s). Following treatment with 5,7-DHT (150 micrograms/30 microliters), a significant increase in seizure severity was observed at 2, 3 and 4 weeks as compared to vehicle-injected controls. The increase in seizure severity was evidenced by a significant increase in the incidence of tonic convulsions in 5,7-DHT treated animals (53% in treated animals compared to 0% in vehicle treated controls) over the testing period. Interestingly, the latency to wild running was increased in 5,7-DHT treated GEPRs, suggesting that depletion of brain 5-HT may slow initiation of AGS. Neurochemical analysis revealed marked depletion of 5-HT in the cortex (-96%), hippocampus (-94%), thalamus (-80%), hypothalamus (-62%), midbrain (-51%) and pons-medulla (-52%) in animals that received 5,7-DHT. However, no significant reductions in brain norepinephrine content were observed in any of the regions assayed due to the pretreatment of all animals with protriptyline. The present findings lend further support for an inhibitory action of brain 5-HT on audiogenic seizures in GEPRs.
AuthorsM A Statnick, M L Maring-Smith, R W Clough, C Wang, J W Dailey, P C Jobe, R A Browning
JournalLife sciences (Life Sci) Vol. 59 Issue 21 Pg. 1763-71 ( 1996) ISSN: 0024-3205 [Print] Netherlands
PMID8937503 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Serotonin Agents
  • 5,7-Dihydroxytryptamine
  • Serotonin
  • Norepinephrine
Topics
  • 5,7-Dihydroxytryptamine (administration & dosage, pharmacology)
  • Acoustic Stimulation
  • Animals
  • Brain (metabolism)
  • Disease Susceptibility
  • Epilepsy
  • Injections, Intraventricular
  • Male
  • Norepinephrine (metabolism)
  • Rats
  • Seizures (metabolism)
  • Serotonin (metabolism)
  • Serotonin Agents (administration & dosage, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: